Cardiex Share Price and Company Fundamentals



Price
$0.052
Change
0.000 (0.000%)
52 week
0.048 - 0.1

Last traded: Today at 1:20 AM

CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. The company develops, markets, and distributes XCEL and Oscar 2 medical devices for the management and diagnosis of hypertension, cardiovascular disease, and other related vascular disorders. It also develops and markets home health devices, wearables, and consumer and medical health apps under the CONNEQT name. In addition, the company provides medical devices for measuring arterial stiffness and central blood pressure waveforms. It serves hospitals, clinics, research institutions and pharmaceutical companies. The company was formerly known as AtCor Medical Holdings Limited and changed its name to CardieX Limited in June 2018. CardieX Limited was founded in 1994 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

7.09

Dividend yield

Beta

2.10

Market cap

-

Enterprise value

-

Company profile

Primary activitiesThe development and marketing of the SphygmoCor device used for cardiovascular patient assessment and management.
Industry / SectorMedical Devices / Healthcare
Websitehttps://cardiex.com
Mailing address15 Lime Street Suite 303 Sydney NSW 2000 Australia
Phone / Fax61 2 9874 8761 /
Share registryLINK MARKET SERVICES LIMITED

Dividends

Cardiex does not pay dividends.

Company Executives

As of Jan 2022, following are the company executives and directors listed on Cardiex.

NameTitleAgeTotal Pay
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICDCo-Founder & Exec. Chairman57204k
Mr. Craig R. CooperCo-Founder, CEO, MD & Exec. Director528.95k
Mr. Jarrod Travers White B.Bus, C.A., CA, CTACFO, Joint Company Sec. & Exec. Director102k
Mr. Chris DaxVP of Operations & Pres of ATCOR Medical
Carol TargosAccounts Mang.
Ahmad QasemChief Science & Research Officer
Mr. Antony SloanGlobal Head of Marketing & Communications
Mr. ZiHan LinVP of Corp. & Bus. Devel.
Mr. Douglas T. KurschinskiExec. VP & Head of Global Sales for AtCor Medical Division
Dr. Steven KestenChief Medical Officer63

Profitability and management effectiveness

Profit margin

-100.02%

Operating margin

-88.82%

Return on assets

-28.06%

Return on equity

-80.43%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Cardiex is and its enterprise value is .

The CDX's stocks Beta value is 2.10 making it 110% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Cardiex (CDX)

Cardiex (ASX:CDX) Frequently Asked Questions

1. What is Cardiex's Stock Symbol?

Cardiex trades on ASX under the ticker symbol "CDX".

2. What is Cardiex's stock price today?

One share of CDX stock can currently be purchased for approximately $0.052.

3. How can I contact Cardiex?

Cardiex's mailing address is 15 Lime Street Suite 303 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9874 8761.

4. What is Cardiex's official website?

The official website of Cardiex is https://cardiex.com.

5. Which share registry manages Cardiex's stock?

Cardiex's stock is managed by LINK MARKET SERVICES LIMITED.